Brazil to receive ingredients from China for more COVID vaccines

Officials say the South American nation will receive enough to produce as many as 25 million AstraZeneca and Sinovac jabs.

Brazil has announced it will receive enough coronavirus vaccine ingredients from China to produce as many as 25 million doses of the AstraZeneca and Sinovac jabs, as the South American nation continues to struggle to vaccinate its population. Rodrigo Cruz, executive secretary of the Brazilian Health Ministry, said the Fiocruz medical research institute would receive two lots of AstraZeneca jab ingredients on Saturday. “The good news is that today I received confirmation that these two lots will be shipped on May 21. It’s enough to produce approximately 18 million doses,” Cruz told a congressional committee hearing on the COVID-19 crisis on Monday.